Oncotype Laboratory Private Limited
About Oncotype Laboratory Private Limited
Data last updated:
Oncotype Laboratory Private Limited was a foreign private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Genomic Health International Holdings Llc. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the diversified business activities segment of the business services sector. It was incorporated on 04 July 2013.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2013FTC245192.
The company had an authorised share capital of ₹55 Lakh and a paid-up capital of ₹45 Lakh. It was led by directors Gordon Bradley Cole and Kim Ellen Mceachron.
Its last annual general meeting (AGM) was held on 29 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at A/5 Labh Apartments Tulsi Baug L T Road Borivali (West), Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2016, the company reported a revenue of ₹15.19 Lakh. For the same year it recorded a net loss of ₹16.05 Lakh (net margin -105.7%) and EBITDA of -₹16.05 Lakh (EBITDA margin -105.7%).
Company details
Contact details
Oncotype Laboratory Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressA/5 Labh Apartments Tulsi Baug L T Road Borivali (West), Mumbai, Maharashtra, India – 400092
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Oncotype Laboratory Private Limited
FY 2016 filings availableOncotype Laboratory Private Limited reported revenue of ₹15.19 Lakh for FY 2016.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹16.05 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹16.05 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -105.7% | |
| Net Profit Margin | -105.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Oncotype Laboratory Private Limited, buy the company report.
Board of directors of Oncotype Laboratory Private Limited
Oncotype Laboratory has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gordon Bradley Cole | Director | 22 Jul 2014 | 12 Years 3 Months | As last reported |
| Kim Ellen Mceachron | Director | 10 Jun 2014 | 12 Years 4 Months | As last reported |
Legal cases
No court or tribunal cases involving Oncotype Laboratory Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oncotype Laboratory Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Oncotype Laboratory Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Oncotype Laboratory Private Limited has 6 board changes on record since 2014: 2 appointments and 4 cessations. The latest: Gordon Bradley Cole ceased to be Additional Director on 29 Sep 2014.
Frequently asked questions
Oncotype Laboratory has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Oncotype Laboratory was a foreign private limited company based in Mumbai, Maharashtra, India. The company worked in miscellaneous business activities, within the business services industry. It was incorporated on 04 July 2013 and is registered under CIN U74999MH2013FTC245192. The company has been struck off by the Registrar of Companies and is no longer operational.
Oncotype Laboratory had 2 directors:
- Gordon Bradley Cole - Director
- Kim Ellen Mceachron - Director
The CIN (Corporate Identification Number) of Oncotype Laboratory is U74999MH2013FTC245192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Oncotype Laboratory is at A5 Labh Apartments Tulsi Baug L T Road Borivali West, Mumbai, Maharashtra, India – 400092.
Oncotype Laboratory was incorporated on 04 July 2013. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Oncotype Laboratory on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 29 September 2016. Year-wise statements from 2015 are in the company report.
Oncotype Laboratory operated in the business services industry, in the miscellaneous business activities segment. It worked in this industry before it was struck off.
Gordon Bradley Cole ceased to be Additional Director on 29 Sep 2014. Kim Ellen Mceachron ceased to be Additional Director on 29 Sep 2014. Dean Lawrence Schorno ceased to be Director on 22 Jul 2014. Oncotype Laboratory has 6 board changes on record in total.
Oncotype Laboratory can be reached at its registered office: A5 Labh Apartments Tulsi Baug L T Road Borivali West, Mumbai, Maharashtra, India – 400092.